Insights

PV Innovation Global pharmacovigilance specialist with a technology-powered platform and 20+ years of expertise presents a strong opportunity to upsell advanced PV workflow automation capabilities to mid-to-large pharma and biotech clients seeking efficiency gains and regulatory clarity.

Acquisition Momentum Recent acquisitions including Insife ApS and Commonwealth Informatics indicate an active growth strategy and integration of software platforms, suggesting sales potential for cross-sell of integrated PV software, data analytics, and consulting services to existing client bases.

Regulatory Focus Participation in industry events like DIA Europe and relationships with health authorities highlight demand for compliant, scalable PV solutions—a cue to position end-to-end regulatory-grade pharmacovigilance offerings to life sciences organizations navigating diverse regional requirements.

Tech-Driven Platform Technology stack featuring Docker, Kubernetes, PostgreSQL and cloud/web platforms signals readiness for enterprise deployments; target customers with complex PV operations seeking reliability, automation, and scalable infrastructure.

Revenue Scale Mid-market to large enterprise target segment implied by revenue range and employee count; identify prospects in the 500–1,000 employee range seeking strategic PV partnerships to consolidate vendors and reduce fragmentation.

Similar companies to Qinecsa Solutions

Qinecsa Solutions Tech Stack

Qinecsa Solutions uses 8 technology products and services including LinkedIn Ads, Microsoft Advertising, Docker, and more. Explore Qinecsa Solutions's tech stack below.

Qinecsa Solutions's Email Address Formats

Qinecsa Solutions uses at least 2 email formats:
Qinecsa Solutions Email FormatsExamplePercentage
First.Last@qinecsa.comJohn.Doe@qinecsa.com
98%
FLast@qinecsa.comJDoe@qinecsa.com
2%

Frequently Asked Questions

What is Qinecsa Solutions's official website and social media links?

Minus sign iconPlus sign icon
Qinecsa Solutions's official website is qinecsa.com and has social profiles on LinkedIn.

How much revenue does Qinecsa Solutions generate?

Minus sign iconPlus sign icon
As of August 2026, Qinecsa Solutions's annual revenue is estimated to be $25M - $50M.

What is Qinecsa Solutions's NAICS code?

Minus sign iconPlus sign icon
Qinecsa Solutions's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Qinecsa Solutions have currently?

Minus sign iconPlus sign icon
As of August 2026, Qinecsa Solutions has approximately 911 employees across 4 continents, including Asia, Europe and North America. Key team members include Chief Executive Officer: A. S., Chief Operating Officer: J. C. and Chief Commercial Officer: A. L. Explore Qinecsa Solutions's employee directory with LeadIQ.

What industry does Qinecsa Solutions belong to?

Minus sign iconPlus sign icon
Qinecsa Solutions operates in the Pharmaceutical Manufacturing industry.

What technology does Qinecsa Solutions use?

Minus sign iconPlus sign icon
Qinecsa Solutions's tech stack includes LinkedIn Ads, Microsoft Advertising, Docker, Kubernetes, PostgreSQL, WP Engine, KnowBe4 and Vimeo.

What is Qinecsa Solutions's email format?

Minus sign iconPlus sign icon
Qinecsa Solutions's email format typically follows the pattern of First.Last@qinecsa.com. Find more Qinecsa Solutions email formats with LeadIQ.

When was Qinecsa Solutions founded?

Minus sign iconPlus sign icon
Qinecsa Solutions was founded in 2006.
Qinecsa Solutions logo

Qinecsa Solutions

Pharmaceutical ManufacturingEngland, United Kingdom501-1000 Employees

Qinecsa Solutions is a global pharmacovigilance specialist based in London, England. It combines more than 20 years of scientific expertise with a technology-powered platform to tackle complex drug safety challenges. By reducing fragmentation and delivering greater clarity and accountability, it helps pharma, biotech, and public health organizations manage risk with greater confidence. As an independent partner in pharmacovigilance, it serves leading life sciences companies and health authorities worldwide to elevate patient safety. In March 2024, Qinecsa Solutions UK Ltd. acquired Insife ApS, expanding its software and consultancy capabilities in pharmacovigilance platforms. It operates as a mid-sized firm serving a global client base.

Section iconCompany Overview

NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2006
Employees
501-1000

Section iconFunding & Financials

  • $25M - $50M

    Qinecsa Solutions's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.